Targeting the SARS-CoV-2 reservoir in long COVID

Ageing and inflammation limit the induction of SARS-CoV-2-specific CD8+ T cell responses in severe COVID-19

Identification of soluble biomarkers that associate with distinct manifestations of long COVID

SARS-CoV-2 S1 subunit produces a protracted priming of the neuroinflammatory, physiological, and behavioral responses to a remote immune challenge: A role for corticosteroids

Data-independent LC-MS/MS analysis of ME/CFS plasma reveals a dysregulated coagulation system, endothelial dysfunction, downregulation of complement machinery

Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection

A causal link between autoantibodies and neurological symptoms in long COVID

Neuroinflammation in post-acute sequelae of COVID-19 (PASC) as assessed by [11C]PBR28 PET correlates with vascular disease measures

Plasma-based antigen persistence in the post-acute phase of COVID-19

Sex differences in symptomatology and immune profiles of Long COVID

Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2

Complement dysregulation is a predictive and therapeutically amenable feature of long COVID